Pharma

AbbVie and Tentarix Biotherapeutics Join Forces for the Development of Biologics for Oncology and Immunology

AbbVie and Tentarix Biotherapeutics Join Forces for the Development of Biologics for Oncology and Immunology

Shots: AbbVie and Tentarix have entered into a multi-year collaboration to discove...

Immunocore Partners with BMS to Develop IMC-F106C in the P-III (PRISM-MEL301) Trial for the Treatment of Melanoma

Immunocore Partners with BMS to Develop IMC-F106C in the P-III (PRISM-MEL301) Trial for the Treatment of Melanoma

Shots: Immunocore & BMS have signed a clinical trial collaboration and supply...

Biocytogen and Gilead Partner to Select and Develop Therapeutic Targets for the Treatment of Multiple Diseases

Biocytogen and Gilead Partner to Select and Develop Therapeutic Targets for the Treatment of Multiple Diseases

Shots: Biocytogen has signed an antibody evaluation and option agreement with Gile...

Immune-Onc Therapeutics and Roche Collaborate to Develop IO-108 for Treating Advanced Hepatocellular Carcinoma

Immune-Onc Therapeutics and Roche Collaborate to Develop IO-108 for Treating Advanced Hepatocellular Carcinoma

Shots: Immune-Onc has entered into a clinical trial collaboration with Roche to in...

Ono Pharmaceutical and InveniAI Collaborate to Identify Novel Therapeutic Targets Using Artificial Intelligence (AI) and Machine Learning (ML)

Ono Pharmaceutical and InveniAI Collaborate to Identify Novel Therapeutic Targets Using Artificial Intelligence (AI) and Machine L...

Shots: Ono and InveniAI have signed a research collaboration agreement for the ide...

Almirall and Novo Nordisk Join Forces for the Development of NN-8828 to Treat Dermatological Diseases

Almirall and Novo Nordisk Join Forces for the Development of NN-8828 to Treat Dermatological Diseases

Shots: Almirall and Novo Nordisk have signed an exclusive license agreement for ri...

Image